MYH14 and type 2 diabetes mellitus: Identification of these changes offers promising avenues for drug discovery, as they suggest that, if myosin biochemical and structural states were to be targeted pharmacologically and restored in type 2 diabetes, this would potentially help to increase the overall muscle/whole-body ATP consumption and thereby promote metabolic health.